Skip to main content
Premium Trial:

Request an Annual Quote

EMBL Launches Online Chemogenomic Database

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The European Molecular Biology Laboratory has launched an online compound database of information on the properties of over 500,000 drug and drug-like small molecules and their targets, including genomic and chemical data, for use in drug discovery research.

Hosted by EMBL's European Bioinformatics Institute, the ChemBLdb holds genomic and chemical data that can be used to help determine whether a particular molecule has the correct sequences to make an effective drug.

EMBL-EBI also has released an integrated resource for sequence, compound, and screening data for protein kinases.

The ChemBLdb is funded with support from Wellcome Trust, according to EMBL-EBI.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.